Many of today’s approved medicines trace their origins to natural sources. For instance, the bark of willow trees, often called nature’s aspirin, contains salicin—a compound that the human body converts into salicylic acid to relieve pain and reduce fever. Building on this long-standing connection between nature and healing, researchers are now exploring new ways to harness naturally occurring compounds to fight complex diseases like cancer.
Tropical Fruit Molecule Inspires Breakthrough
A research team led by William Chain, Associate Professor in the Department of Chemistry and Biochemistry at the University of Delaware, has developed a promising method to fight liver-related cancers, which rank among the leading causes of cancer deaths worldwide.
Using a process known as natural product total synthesis, Chain and his team created a new chemical pathway to produce molecules found in guava plants. These molecules have been shown to possess potent anti-cancer properties. The study was recently published in the prestigious international journal Angewandte Chemie.
Making Cancer-Fighting Molecules Accessible
As per the University of Delaware press release, the team’s innovative approach enables scientists to use readily available and inexpensive chemicals to produce these complex natural molecules in the laboratory. This not only provides a low-cost method for large-scale synthesis but also opens the door to more affordable cancer treatments.
“The majority of clinically approved medicines are either made from a natural product or are based on one,” said Chain. “However, there aren’t enough natural resources to meet global treatment needs. Our work gives chemists a ‘recipe’ they can follow to synthesize these molecules themselves.”
Collaboration and Scientific Progress
The breakthrough also encourages collaboration across the scientific community. Liam O’Grady, a doctoral student in Chain’s lab and the paper’s first author, highlighted the team’s pioneering role: “We’re the first to pave that road, and now others can refine it—finding shortcuts or alternative routes. By exploring this unknown pathway, we’ve shed light on how to get there, and that’s the exciting part.”
Addressing a Growing Global Health Burden
This discovery could have a far-reaching impact. Liver and bile duct cancer cases have risen sharply in recent years. Globally, experts project that one in 125 people will develop hepatocellular carcinoma, the most common type of liver cancer. In the United States alone, doctors expect more than 42,000 new cases in 2025 and anticipate over 30,000 deaths.
Current chemotherapy treatments for liver cancer are expensive and often ineffective in advanced stages, with five-year survival rates below 15%. By offering a more sustainable and cost-effective way to create cancer-fighting compounds, the Delaware team’s work could change this outlook.
Next Steps: Exploring Wider Applications
The researchers are now collaborating with the National Cancer Institute (NCI) to explore the potential of the guava derived molecule in combating other types of cancers. If successful, this could mark a significant step toward broad-spectrum natural compound–based cancer therapies.